Medicure Inc V.MPH

Alternate Symbol(s): MCUJF

Healthcare Biotechnology

Medicure Inc. is a pharmaceutical company. It is focused on the development and commercialization of pharmaceuticals and healthcare products for patients and prescribers in the United States market. The focus of it is the marketing and distribution of AGGRASTAT (tirofiban hydrochloride) injection and ZYPITAMAG (pitavastatin) tablets in the United States, where they are sold through the Company's United States subsidiary, Medicure Pharma Inc. It also operates Marley Drug Inc. (Marley Drug), a pharmacy subsidiary servicing all 50 states, Washington D.C. and Puerto Rico. Marley Drug is committed to improving access to medication for all Americans together with exceptional customer service and free home delivery. AGGRASTAT is indicated to reduce the rate of thrombotic cardiovascular events in patients with non-ST elevation acute coronary syndrome. It also develops pyridoxal 5'-phosphate analogues (P5P Analogues), the processes for their preparation, compositions containing P5P Analogues.

TSXV:MPH - Post by User

Medicure Inc

Bullboard Posts

Comment by kgranton May 08, 2008 2:49pm

566 Views

Post# 15052662

RE: re-MC-1-Works!! re-Yahoo Board

I guess Stockhouse doesn't like a post containing a few unusual characters strung together like !, @, #, $, ^, %, *, &, etc. Just wanted to say I'm glad I sold my shares of this POS even though I lost a "insert characters" amount of money on it.

And I see we're grasping at MC-1 straws that are based on the Ph2 901-patient study? How long ago was that?

Bullboard Posts

First Helium advances winter drilling program with Leduc Anomaly test well